| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 46,385 | 46,475 | 26.03. | |
| 46,350 | 46,670 | 26.03. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 650,00 | 4 | |||
| 170,00 | 8 | |||
| 135,00 | 57 | |||
| 60,00 | 15 | |||
| 55,00 | 44 | |||
| 52,20 | 500 | |||
| 51,76 | 50 | |||
| 46,670 | 180 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 180 | 46,350 | |||
| 37 | 36,000 | |||
| 120 | 20,800 | |||
| 300 | 20,000 | |||
| 1.052 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.689 | 0,508 | 858 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 16:58:31 | 46,455 | 6 |
| 16:51:17 | 46,535 | 37 |
| 16:51:17 | 46,610 | 53 |
| 15:42:35 | 47,040 | 44 |
| 15:17:35 | 46,890 | 125 |
| 15:14:36 | 46,690 | 7 |
| 15:14:36 | 46,690 | 193 |
| 14:52:31 | 46,690 | 16 |
| 14:38:07 | 46,010 | 169 |
| 14:30:03 | 45,705 | 55 |
| 14:30:03 | 45,705 | 136 |
| 14:19:13 | 45,755 | 75 |
| 13:08:25 | 45,785 | 125 |
| 12:05:49 | 45,940 | 16 |
| 12:05:49 | 45,940 | 190 |
| 10:53:23 | 45,845 | 11 |
| 10:48:02 | 45,700 | 6 |
| 10:48:02 | 45,925 | 190 |
| 10:00:00 | 46,100 | 2 |
| 09:38:09 | 45,960 | 13 |
| Tagesumsatz Xetra | -0,155 -0,33 % | 2.665 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Moderna Stock is Soaring. Is It Too Late to Buy? | 19 | The Motley Fool | ||
| Di | Moderna stands as the best performing large-cap healthcare stock YTD | 18 | Seeking Alpha | ||
| 19.03. | Pfizer vs Moderna: Which Pharma Stock Has More Upside? | 45 | The Motley Fool | ||
| 17.03. | Moderna CEO Stéphane Bancel's 2025 pay hits $19.9M as cash bonus more than doubles | 43 | FiercePharma | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| 13.03. | GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy | 67 | FiercePharma |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | ACCESS Newswire | - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome -- Dermata plans to launch its first DTC product, our Foundational... ► Artikel lesen | |
| Do | EQS-News: Wall Street Wire: Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD) | EQS Group (DE) | EQS-News: Wall Street Wire
/ Schlagwort(e): Sonstiges
Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD)
26.03.2026... ► Artikel lesen | |
| Do | ViroGates A/S: ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues | GlobeNewswire (Europe) | Company Announcement no. 1/2026 (March 26, 2026 at 15:10:00 CET)
Inside information
BIRKERØD, DENMARK ViroGates A/S ("ViroGates" or "Company"), a medical technology company developing blood tests for... ► Artikel lesen | |
| Do | BioInvent International: BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis | ACCESS Newswire | BioInvent International (STO:BINV) - Achievement of the milestone triggers a payment of € 1 million LUND, SE / ACCESS Newswire / March 26, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV)... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.03.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 26.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.03.2026.ISIN NameCA2568277834 DOLLY... ► Artikel lesen |